Vimarsana
Biggest News Aggregation in the World

Page 2 - Hamill Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hamill Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hamill Foundation Today - Breaking & Trending Today

HBU Celebrates the Life and Legacy of Mary Ann Belin | Houston Baptist University - Vimarsana News

HBU Celebrates the Life and Legacy of Mary Ann Belin | Houston Baptist University

HBU celebrates the life and legacy of Mary Ann Belin who passed away on Wednesday, June 1, 2022, at the age of 92. Mrs. Belin and her late husband, Dr. Bruce Belin, Jr., were faithful and generous supporters of Houston Baptist University (HBU) throughout the years. Mrs. Belin was a longtime memb ...

Source: hbu.edu
Molecular profiling of meningioma can lead to improved prognosis and therapy - Vimarsana News

Molecular profiling of meningioma can lead to improved prognosis and therapy

Reliably predicting whether meningioma, the most common primary brain tumor, will recur or remain benign has not been easy. In this study, published

Haven River Inn Chapel project near completion - Vimarsana News

Haven River Inn Chapel project near completion

Thu, 03/04/2021 - 12:00am By:  Ronni Walker | Mmc Under the guidance of Lamb’s Tale Ministries, the Haven River Inn, a 501(c)(3) not-for-profit organization, provides respite care for those in full-time ministry. Lamb’s Tale Ministries’ mission is to allow those serving in ministry a time to reflect on their calling and have an opportunity to refresh their minds and souls. Lamb’s Tale Ministries relies solely on donors to provide the funds necessary for their stay. The Haven River Inn is compensated at a reduced rate for this service to help serve God’s purpose. In 20...

Antisense oligonucleotides as a feasible therapy to treat MECP2 duplication disorder - Vimarsana News

Antisense oligonucleotides as a feasible therapy to treat MECP2 duplication disorder

 E-Mail Many cognitive neurodevelopmental disorders are a result of too many or too few copies of certain genes or chromosomes. To date, no treatment options exist for this class of disorders. MECP2 duplication syndrome (MDS) is one such disorder that primarily affects boys and results from a duplication spanning the methyl-CpG binding protein 2 (MECP2) locus located on the X chromosome. A preclinical study published from the laboratory of Dr. Huda Zoghbi, professor at Baylor College of Medicine and director of the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospit...